BC Platforms AG

www.bcplatforms.com

Portfolio
Venture Capital

Industry
Healthcare and life sciences

Manager
Joni Karsikas

Investment Year
2017

Sales m€
2,1 (2016)

Personnel
30

BC Platforms is a world-leader in genomic data management solutions. Company’s vision is to provide the world’s leading analytics platform for healthcare and industry, with access by 2020 to over 5 million subjects’ diverse genomic and clinical data and samples consolidated from a global network of biobanks.

News
9.5.2017

BC Platforms Closes USD $10 million Series B Financing led by Debiopharm and Tesi to accelerate knowledge platform development

News
18.12.2019

BC Platforms Closes USD $15 million Series C Financing and Signs Partnership with IQVIA to extend Data Analytics in Genomics

Tesi in a nutshell

Tesi (Finnish Industry Investment Ltd) is a state-owned venture capital and private equity company that wants to raise Finland to the forefront of renewed economic growth. We invest in venture capital and private equity funds and directly in growth companies.

Tesi (Finnish Industry Investment Ltd)
Porkkalankatu 1 PL 685 , 00180 Helsinki
info@tesi.fi | @TesiFII

BC Platforms Closes USD $10 million Series B Financing led by Debiopharm and Tesi to accelerate knowledge platform development

BC Platforms Closes USD $15 million Series C Financing and Signs Partnership with IQVIA to extend Data Analytics in Genomics

Tesi

Portfolio

News

Contact